Azithromycin (Azithm 250) is a macrolide antibiotic used for various bacterial infections such as infections of the middle ear, throat, bronchus, sinuses, skin and soft tissue. It is also useful in ...

BOS may be the result of immunologic injury targeting both endothelial and epithelial tissues in the pulmonary system, and such immunologic damage may represent cGVHD, or can be induced and aggravated ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Bronchiolitis obliterans syndrome (BOS), defined as new fixed airflow obstruction that develops in the setting of active chronic GVHD (cGVHD), is a serious and ...

May 24, 2011 (Denver, Colorado) — The addition of daily azithromycin to conventional treatment for chronic obstructive pulmonary disease (COPD) significantly helps reduce acute exacerbations ...

The National Pharmaceutical Pricing Authority (NPPA) has released the revised calculation sheet for the ceiling price of azithromycin 250 mg tablet following a review order from the Department of ...

In 1982, after investing eight years of effort, Pfizer was preparing to end its work in macrolide research. Its work in finding an improved version of erythromycin had come up empty. But, as happens ...

An extended course of low-dose azithromycin (multiple brands) may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD) ...

Please provide your email address to receive an email when new articles are posted on . Long-term azithromycin treatment increased lumen radius and lumen area in patients with severe persistent asthma ...

Epidemiologic, laboratory, animal, and clinical studies suggest that there is an association between Chlamydia pneumoniae infection and atherogenesis. We evaluated the efficacy of one year of ...